Weld Capital Management’s AnaptysBio ANAB Stock Holding History

Weld Capital Management’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,722	Closed	-$345K	–	723
2019 Q1	$345K	Buy	+4,722	New	+$326K	0.06%	481

Other funds holding ANAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Weld Capital Management's ANAB Position: Q2 2019 in Review

Weld Capital Management sold out of AnaptysBio (ANAB) in Q2 2019, closing a stake of 4,722 shares — an estimated $345K sold.

Weld Capital Management first reported a position in ANAB in Q1 2019 and held it in 1 quarter. The position peaked at $345K in Q1 2019. 127 funds tracked by Wall St. Rank hold ANAB as of Q2 2019.

Weld Capital Management reported no remaining AnaptysBio position as of Q2 2019 after selling out during the quarter.
Weld Capital Management sold 4,722 AnaptysBio shares in Q2 2019, an estimated $345K.
Weld Capital Management first reported a position in AnaptysBio in Q1 2019 and held it in 1 quarter.
Weld Capital Management's AnaptysBio position peaked at $345K in Q1 2019.
127 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2019.

Based on Weld Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.